The acquisition of FMC Corporation's health and nutrition business gives DowDuPont “one of the broadest pharma offerings to serve the growing excipients industry,” the firm says.
FMC BioPolymer said today that effective 15 October, it will
increase prices for its pharmaceutical and food brand products by 5
to 10 per cent on average, blaming increases in its own costs.
FMC BioPolymer is making progress in its collaboration with
BioProgress and Harro Hoefliger on a machine to produce its
recently-acquired NROBE tablet coating technology.
Tablet-coating specialist BioProgress formalised its agreement with
US chemicals and machinery group FMC in deal that could be worth up
to $160 million (€128m) in revenues in the first six years.